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The antimicrobial effects of the 
alginate oligomer OligoG CF-5/20 
are independent of direct bacterial 
cell membrane disruption
Manon F. Pritchard1, Lydia C. Powell1, Saira Khan1, Peter C. Griffiths2, Omar T. Mansour2, 
Ralf Schweins3, Konrad Beck1, Niklaas J. Buurma4, Christopher E. Dempsey5, Chris J. Wright6, 
Philip D. Rye7, Katja E. Hill1, David W. Thomas1,* & Elaine L. Ferguson1,*
Concerns about acquisition of antibiotic resistance have led to increasing demand for new antimicrobial 
therapies. OligoG CF-5/20 is an alginate oligosaccharide previously shown to have antimicrobial and 
antibiotic potentiating activity. We investigated the structural modification of the bacterial cell wall 
by OligoG CF-5/20 and its effect on membrane permeability. Binding of OligoG CF-5/20 to the bacterial 
cell surface was demonstrated in Gram-negative bacteria. Permeability assays revealed that OligoG 
CF-5/20 had virtually no membrane-perturbing effects. Lipopolysaccharide (LPS) surface charge and 
aggregation were unaltered in the presence of OligoG CF-5/20. Small angle neutron scattering and 
circular dichroism spectroscopy showed no substantial change to the structure of LPS in the presence 
of OligoG CF-5/20, however, isothermal titration calorimetry demonstrated a weak calcium-mediated 
interaction. Metabolomic analysis confirmed no change in cellular metabolic response to a range of 
osmolytes when treated with OligoG CF-5/20. This data shows that, although weak interactions occur 
between LPS and OligoG CF-5/20 in the presence of calcium, the antimicrobial effects of OligoG CF-5/20 
are not related to the induction of structural alterations in the LPS or cell permeability. These results 
suggest a novel mechanism of action that may avoid the common route in acquisition of resistance via 
LPS structural modification.
Multi-drug resistant (MDR) bacteria represent a major global health challenge with soaring morbidity and 
mortality1. Furthermore, as the acquisition of resistance now supersedes the rate of development of new antibiotics, 
the need for novel antimicrobial therapies is urgent2. OligoG CF-5/20 is a low molecular weight (Mn 3,200 g/mol) 
alginate derived from the stem of the seaweed Laminaria hyperborea3. OligoG CF-5/20 potentiates the effect 
of conventional antimicrobials against a range of bacteria3 and fungi4, and disrupts biofilm formation of MDR 
pathogens both in vitro and in vivo5. However, the mechanism by which OligoG CF-5/20 exerts its antimicrobial 
effects is still unclear. OligoG CF-5/20 has been proven safe for human clinical use and has completed Phase 2b 
clinical studies (NCT02157922; NCT02453789) as an inhalation therapy for cystic fibrosis (CF) patients.
CF is an autosomal recessive disorder causing an imbalance in ion exchange across the respiratory airway6, 
leading to thick mucus stasis, which is ultimately chronically colonised by opportunistic pathogens, principally 
Pseudomonas aeruginosa7. CF patients are especially at risk of harbouring MDR bacteria due to the presence of 
chronic lung infection, compounded by intense and frequent use of multiple antibiotics from childhood. Having 
previously demonstrated that OligoG CF-5/20 treatment was effectively associated with disruption of planktonic 
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and biofilm growth of P. aeruginosa3,8,9, and that this effect was independent of an interaction with the P. aeruginosa 
mexAB-oprM efflux pump system3, this study sought to investigate whether OligoG CF-5/20 exerts its antibiotic 
potentiation effects (up to 512-fold) via direct interaction with the bacterial cell.
Whilst many antimicrobials act on the biosynthetic pathways of growing cells, the bacterial membrane rep-
resents an important target in the treatment of quiescent non-replicating bacteria in recalcitrant infection such 
as in the CF lung10. A number of agents have been developed that modulate changes in the bacterial membrane 
directly, via alterations in NADH2 and ATP synthase, and indirectly, via generation of lethal reactive oxygen spe-
cies and nitric oxide in the bacterial membrane. Membrane-active antibiotics, such as the polymyxins, including 
colistin (polymyxin E) and polymyxin B, and amphipathic antimicrobial peptides, such as RTA311, act synergisti-
cally with other drugs to enhance their internalisation and access to intracellular targets12.
OligoG CF-5/20 modifies the surface charge of P. aeruginosa, inducing cellular aggregation and a reduction 
in bacterial motility8; changes which are associated with decreased mechanical strength of the biofilm structure9. 
A combination effect of OligoG CF-5/20 and the antimicrobial triclosan against the oral pathogens Streptococcus 
mutans (Gram-positive) and Porphyromonas gingivalis (Gram-negative) led to a decrease in attachment to sur-
faces such as titanium13. Following the reported interaction of OligoG CF-5/20 with both these Gram-negative 
and Gram-positive pathogens, a greater understanding of the interaction of the oligosaccharide with the cell 
wall was sought. Gram-positive bacteria have a single lipid membrane surrounded by a 30–100 nm thick pep-
tidoglycan/lipoteichoic acid cell wall14, which is tightly cross-linked by inter-peptide bridges and has a phos-
phoryl group located in the substituent teichoic and teichuronic acid residues, and un-substituted carboxylate 
groups (Fig. 1a). In comparison, Gram-negative bacteria have a very thin, loosely cross-linked peptidoglycan, 
which is sequestered within the periplasmic space, between the inner and outer lipid membranes. Phosphoryl 
and 2-keto-3-deoxyoctonate carboxylated groups of lipopolysaccharide (LPS) are found in the outer leaflet of the 
outer membrane (Fig. 1b)15. Cell-surface oligosaccharides such as the hydrophilic O-antigen component of LPS in 
Gram-negative bacteria16 also play a role in facilitating biofilm attachment. The highly polyanionic nature of LPS 
maintains the integrity of the outer membrane which is linked electrostatically by divalent cations such as Ca2+ 17. 
The outer membrane of Gram-negative bacteria is selectively resistant to noxious agents due to its effective per-
meability barrier function (enabling hydrophobic drugs to diffuse across the lipid bilayer, whilst small hydrophilic 
drugs use the porins to gain access to the cell). Both Gram-positive and Gram-negative bacteria have an overall 
negative electrostatic surface charge.
Here we present a range of nanoscale techniques to analyse the interaction of OligoG CF-5/20 with compo-
nents of the bacterial cell wall and membrane permeability, in particular to P. aeruginosa. Detailed nanoscale 
analysis of the interaction of drugs with the bacterial cell can be used to enhance our understanding of the mech-
anism of action involved in antimicrobial therapy18. Atomic force microscopy (AFM) is fast becoming a common 
tool for analysing nanostructures19 and has been used to study the effect of antimicrobial agents on planktonic 
cells8,20,21 and bacterial biofilms22,23 as well as a range of MDR Gram-negative organisms24,25. Cellular surface 
charge can be analysed using electrophoretic light scattering (ELS), now a standard method for measuring the 
zeta potential26. ELS is often used to explore mechanisms of bacterial adhesion and aggregation to biophysical 
host tissues and biomaterial substrates27–29. Small-angle neutron scattering (SANS) has previously been used to 
characterise the shape and interaction of bio-macromolecules such as antibiotics and polymers with key bacterial 
cell wall components, such as LPS30. Circular dichroism (CD) spectroscopy has been extensively used to charac-
terise antimicrobial peptides31 and analyse their interaction with the bacterial cell wall32,33. Here CD was used to 
monitor whether LPS interacts with OligoG CF-5/20 via its carboxyl groups that show intense Cotton effects near 
Figure 1. Comparison of the effect of OligoG CF-5/20 on Gram-positive and Gram-negative bacteria. 
Diagram representing the cell wall of (a) Gram-positive and (b) Gram-negative bacteria. Atomic force 
microscopy (AFM) images of S. mutans ± 7 mg/ml OligoG CF-5/20 and P. aeruginosa ± 5 mg/ml OligoG CF-
5/20 at (c) 20 μ m2 and (d) 5 μ m2 (S. mutans) and 4 μ m2 (P. aeruginosa).
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200 and 215 nm34. Isothermal titration calorimetry has also previously been employed to elucidate the mecha-
nisms by which novel antimicrobials interact with the cell surface target, LPS35,36.
Results
Comparison of bacterial cell wall and the effect of OligoG CF-5/20. AFM images of Gram-positive 
S. mutans and Gram-negative P. aeruginosa treated with OligoG CF-5/20 (7 and 5 mg/ml respectively), showed 
cellular aggregation, which was not evident in the untreated bacteria (Fig. 1c). OligoG CF-5/20 appeared to sur-
round the cell walls of P. aeruginosa following a centrifugation step, prior to imaging. However, while Gram-
positive S. mutans demonstrated cellular clumping, OligoG CF-5/20 was not visible around the cell surface at the 
nanoscale level upon exposure to centrifugation, when compared to P. aeruginosa (Fig. 1d).
Effect of OligoG CF-5/20 on cell permeability. Having demonstrated that OligoG CF-5/20 causes cel-
lular aggregation in Gram-negative bacteria, with OligoG CF-5/20 surrounding the cell walls, the ability of the 
alginate to permeabilise both simulated (liposomes) and real cell membranes, with propidium iodide (PI), nitro-
cefin (NFN) and 1-N-phenylnaphthylamine (NPN), was studied using conventional permeability assays. Initial 
studies using carboxyfluorescein-loaded unilamellar liposomes showed that, unlike RTA3 under these conditions, 
an amphipathic antimicrobial peptide, OligoG CF-5/20 had virtually no membrane perturbing effects (Fig. 2a), 
although it did produce a slight dose-dependent increase in release of trapped dye (Fig. 2b). Similar results were 
obtained in vesicles composed of PC:PG at a ratio of 50:50 (data not shown).
Correspondingly, in an in vitro model of membrane permeabilisation in P. aeruginosa PAO1, neither PI 
(Fig. 2c) nor NFN (Fig. 2d) were able to enter the cytoplasm and periplasmic space, respectively, in the presence 
of OligoG CF-5/20. As OligoG CF-5/20 is able to bind Ca2+ we also compared its effect to the chelating agent, eth-
ylendiaminetetraacetic acid (EDTA), a chelator which effectively permeabilises the bacterial outer membrane of 
PAO1, allowing internalisation of both the dyes. In a final evaluation of the ability of OligoG CF-5/20 to enhance 
cell permeability, internalisation of NPN dye by three P. aeruginosa strains was assessed. As seen in the other 
assays, OligoG CF-5/20 (up to 20 mg/ml) did not promote partitioning of NPN into bacterial cell membranes, 
which was clearly evident in the presence of the positive control, polymyxin B (Fig. 2e).
Effect of OligoG CF-5/20 under various osmolyte conditions. PAO1 (48 h) showed no changes in 
growth in response to ionic/osmotic stress in the presence of OligoG CF-5/20 (20–60 mg/ml) under all conditions 
tested, including 4% (w/v) urea (Fig. 3a) and 20 mM sodium benzoate pH 5.2 (Fig. 3b).
Surface charge and aggregation of LPS in the presence of OligoG CF-5/20. Having eliminated the 
possibility of cell permeabilising effects, the direct interaction of OligoG CF-5/20 with LPS was studied. First, LPS 
aggregate formation with OligoG CF-5/20 (or colistin sulphate as a positive control) was studied by measuring 
change in turbidity over time. Turbidity remained unaltered in the presence of OligoG CF-5/20 (up to 20 mg/ml), 
although significant differences in turbidity were observed with the positive control, colistin sulphate, which 
rapidly formed aggregates with LPS (Fig. 3c). Surface charge (zeta potential) of pseudomonal LPS alone became 
slightly less negative as the pH increased from pH5 to pH7 and pH9 (− 40.4 mV, − 36.0 mV and − 36.3 mV, 
Figure 2. The effect of OligoG CF-5/20 on bacterial cell membrane permeabilisation. Cell permeability 
assay showing (a) release of carboxyfluorescein (Cbfl) from single lamellar liposomes composed of egg PC:PG 
(80:20) in the presence of RTA3 (0.5 μ M; positive control) or OligoG CF-5/20 at 20–100 mg/ml (b) zoomed-in 
graph of OligoG CF-5/20 only data. Internalisation of (c) propidium iodide (PI) and (d) nitrocefin (NFN) by 
PAO1 compared to EDTA (positive) control (1 mM-20 mM). (e) Internalisation of 1-N-phenylnaphthylamine 
(NPN) dye by P. aeruginosa strains; PAO1, V2 and NH57388A ± 2–20 mg/ml OligoG CF-5/20 and polymyxin B 
(positive control). (AU = arbitrary units). (Data represents mean ± SD; **p < 0.01 and ****p < 0.0001 compared 
to control; n = 3).
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respectively; Fig. 3d) with only a small overall change in charge over this pH range (4.1 mV). In contrast, the zeta 
potential of OligoG CF-5/20 alone showed a greater change in charge (11.4 mV) over the pH range tested, being 
significantly less negative at pH 5 compared to pH 7 and 9 (− 28.6 mV, − 41.7 mV and − 40.0 mV, respectively; 
p < 0.05). However, when OligoG CF-5/20 and LPS were combined, there was no pH-dependent change in sur-
face charge interaction when compared to LPS alone.
Structural interactions of OligoG CF-5/20 with LPS. SANS experiments of LPS showed significant 
scattering intensity I(Q) as a function of the wave-vector, Q, which varied subtly at low Q as a function of ionic 
strength (Fig. 4a) but was largely unaltered by pH (see Supplementary Fig. S1). Pre-incubation of LPS with OligoG 
CF-5/20 had no effect on scattering intensity. However, when LPS was pre-incubated with a positive control, colis-
tin sulphate, a pronounced increase in scattering intensity at low Q was apparent, indicating larger structures. 
Additionally, two peaks appeared at Q = 0.06 and 0.12 Å−1, demonstrating a regular structure of stacked interfaces 
(Fig. 4b). The most striking observation from the SANS experiment, is that the scattering did not change with 
ionic strength or the addition of OligoG CF-5/20. Indeed, when analysing the data in terms of a mixture of vesi-
cles and micelles, not surprisingly, the parameters required to fit the data were also largely constant. The balance 
of the vesicular to micellar components was also invariant with both variables. Noteworthy is the comparison of 
the radius in the micellar term (22 Å), presumably corresponding to the extended length of the LPS molecule, 
versus the thickness of the vesicular lamellae, 46 Å, which one would expect to be double the extended length.
CD spectra recorded under similar conditions showed no apparent conformational changes that could indi-
cate a specific LPS:OligoG CF-5/20 interaction. The spectra resulting after mixing simply corresponded to the 
addition of the individual signals (Fig. 4c,d). This was also found when varying the OligoG CF-5/20 concentration 
between 2 to 20 mg/ml (data not shown). An ionic interaction of LPS with the carboxylates of OligoG CF-5/20 
would be expected to reduce the CD amplitude at ~215 nm and could induce a red-shift of the signal, as observed 
for the interaction with calcium ions37.
The SANS data also showed that Ca2+ at 5 and 10 mM had no effect on the LPS structure over the length scale 
probed (Fig. 5a). The raw data follows a rather less curved form, with just a very weak oscillation. The best fit here 
was found to be a given by the simple unilamellar vesicle with a radius slightly larger than the previous case, but 
with a similar thickness, at least within experimental error, i.e. there was no clear evidence of co-existing smaller 
micelles. The key parameters for all SANS experiments are presented in Table 1. Also, CD spectra for LPS/OligoG 
CF-5/20 interactions measured with and without 5 mM Ca2+ at pH 5 and pH 7 showed no significant differences 
(Fig. 5b).
Biomolecular interactions of OligoG CF-5/20 and LPS. Initially, ITC was employed to record the 
heat effects of OligoG CF-5/20 (20 mg/ml, ~6.25 mM) dilutions. The dilution heat effects of OligoG CF-5/20 
in the presence of 1 mM EDTA showed only a limited decrease, suggesting that the aggregation state of OligoG 
CF-5/20 did not change with increasing concentration. In the presence of 1 mM Ca2+, however, the dilution heat 
effects were not constant and followed the typical pattern for self-aggregating compounds38, which was strongly 
Figure 3. Effect of OligoG CF-5/20 on Pseudomonas aeruginosa PAO1 under various osmolyte conditions 
and on lipopolysaccharide (LPS from P. aeruginosa). Biolog metabolomic osmolyte assay (PM9) representing 
PAO1 ± 20–100 mg/ml OligoG CF-5/20 (a) 4% urea (b) 20 mM sodium benzoate pH 5.2 (48 h). (c) Precipitation 
of LPS from P. aeruginosa (5 mg/ml) ± 2–20 mg/ml OligoG CF-5/20 or 4 mg/ml colistin sulphate (positive 
control). (Data represents mean ± SD, n = 3). (d) Mean zeta potential measurements of 2 mg/ml OligoG CF-
5/20 and 10 mg/ml LPS in 0.01 M NaCl buffer at pH 5, 7 and 9.
www.nature.com/scientificreports/
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Figure 4. Structural analysis of LPS ± OligoG CF-5/20. Small-angle neutron scattering from LPS (10 mg/ml) 
in D2O containing 0.001 to 0.1 M NaCl at pH 7 (a) alone and (b) following incubation (3 h at 37 °C) with OligoG 
CF-5/20 (20 mg/ml). Circular dichroism spectra of LPS (10 mg/ml) and OligoG CF-5/20 (20 mg/ml) in 0.1 M 
NaCl at (c) pH 5 and (d) pH 7 were recorded at 37 °C. OligoG CF-5/20 spectra in the absence and presence of 
10 mg/ml LPS are shown in blue and red, respectively; the difference of the spectra is shown in green.
Figure 5. LPS analysis in the presence of divalent cations. (a) Small-angle neutron scattering (SANS) analysis 
of LPS (10 mg/ml) and OligoG CF-5/20 (20 mg/ml) in the presence of 5 or 10 mM Ca2+ in 0.01 or 0.10 M 
NaCl at pH 7. (b) Circular dichroism spectra of 20 mg/ml OligoG CF-5/20 in the presence of 10 mg/ml LPS in 
0.10 M NaCl were recorded in the presence and absence of 5 mM Ca2+ at pH 5 and pH 7 at 37 °C; buffer spectra 
including LPS were subtracted.
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suggestive of OligoG CF-5/20 aggregation in the presence of added Ca2+. (Data obtained in the presence of 1 mM 
CaCl2 was comparable to titrations in the presence of 1 mM EDTA and 2 mM CaCl2, see Supplementary Fig. S2).
Further studies were conducted to determine the interaction between OligoG CF-5/20 and LPS, both in the 
presence of 1 mM EDTA or CaCl2 and when combining 1 mM EDTA and 2 mM CaCl2. In the presence of EDTA 
alone, (i.e. in the absence of free Ca2+) the heat effects for injection of OligoG CF-5/20 into LPS did not deviate 
significantly from the combined heat effects for the reference dilution experiments (Fig. 6a). This observation 
suggested that in the absence of free Ca2+, OligoG CF-5/20 and LPS do not interact at the concentrations used in 
these experiments. Contrastingly, in the presence of 1 mM added CaCl2, (or 1 mM EDTA and 2 mM CaCl2), the 
heat effects observed for injection of OligoG CF-5/20 into LPS were markedly different from the combined heat 
effects for the reference dilution experiments. In particular, whilst de-aggregation of OligoG CF-5/20 upon dilu-
tion was exothermic (vide supra), interaction of OligoG CF-5/20 with LPS was endothermic, strongly suggesting 
that OligoG CF-5/20 and LPS interact in the presence of calcium (Fig. 6b). The lack of a sigmoidal shape to the 
enthalpogram suggested, however, that the interaction was weak39.
Discussion
OligoG CF-5/20 is a new antimicrobial therapy, demonstrating promising results across the microbial kingdom 
in both eubacteria and yeasts. Effective synergistic enhancement of current antimicrobials has previously been 
demonstrated in both Gram-positive13 and Gram-negative bacteria3. This study focused on the nanoscale inter-
action of OligoG CF-5/20 with the Gram-negative cell surface, following strong, irreversible binding to the cell 
wall after centrifugation. OligoG CF-5/20 has previously been shown to remain bound to the pseudomonal cell 
surface, leading to cellular aggregation, even following exposure to hydrodynamic shear8.
LPS in D2O, pH7 R1 (±5)/Å R2 (±10)/Å Thickness (±5)/Å
LPS, no salt† n/a 1150 40
1 mM NaCl 22 710 45
1 mM NaCl + OligoG 21 709 45
10 mM NaCl 22 710 46
10 mM NaCl + OligoG 22 709 46
100 mM NaCl 23 710 46
100 mM NaCl + OligoG 21 712 46
10 mM NaCl + OligoG, 5 mM Ca2+† n/a 1150 45
10 mM NaCl + OligoG, 10 mM Ca2+† n/a 1150 45
100 mM NaCl + OligoG, 5 mM Ca2+† n/a 1150 43
100 mM NaCl + OligoG, 10 mM 
Ca2+† n/a 1150 48
Table 1.  Structural parameters of LPS assuming spherical micelles (radius R1) and unilamellar vesicles 
(radius R2) and lamellae thickness. The mass fraction and composition of materials have been constrained to 
physically reasonable values in the fitting routine. The concentrations of LPS and OligoG CF-5/20 were 10 and 
20 mg/ml, respectively. †A vesicular structure model, looking at the absolute scattering intensities, was utilised 
(Bello et al. 2014).
Figure 6. Interaction between OligoG CF-5/20 and LPS. (a) Heat effects per injection (qi) for the titration of 
20 mg/ml OligoG CF-5/20 into 10 mg/ml LPS (▪ ), 20 mg/ml OligoG CF-5/20 into buffer (o), buffer into  
10 mg/ml LPS (Δ ), and buffer into buffer (∇ ) at 37 °C (buffer is 20 mM phosphate pH 7, 100 mM NaCl, 1 mM 
EDTA). (b) Heat effects per injection (qi) for the titration of 20 mg/ml OligoG CF-5/20 into 10 mg/ml LPS (▪ ),  
20 mg/ml OligoG CF-5/20 into buffer (o), buffer into 10 mg/ml LPS (Δ ), and buffer into buffer (∇ ) at 37 °C 
(buffer is 20 mM phosphate pH 7, 100 mM NaCl, 1 mM EDTA).
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Structural analysis of pseudomonal biofilms has previously indicated that OligoG CF-5/20 treatment was asso-
ciated with increased water channels as demonstrated by scanning electron and confocal laser scanning micros-
copy studies3 and a decrease in biofilm mechanical strength as shown by rheological analysis and AFM force 
measurements9. Clear differences were seen at the nanoscale level, showing significantly greater surface inter-
action of OligoG CF-5/20 with the Gram-negative cell wall of P. aeruginosa, which remained attached to the P. 
aeruginosa cell wall, and resisted hydrodynamic shear8. A previous study quantified the alteration in PAO1 surface 
charge and aggregation using electrophoretic and dynamic light scattering, and confirmed the irreversible bind-
ing between OligoG CF-5/20 and the cell surface8. No change in surface charge was seen with the Gram-positive 
S. mutans when treated with OligoG CF-5/20 following hydrodynamic shear (Supplementary Fig. S3). The pres-
ence of a dense layer of LPS is unique to Gram-negative bacteria and provides an effective (although selective) 
permeability barrier40. We hypothesised that OligoG CF-5/20 may directly interact with LPS to reduce biofilm 
formation and further experiments were conducted solely in Gram-negative P. aeruginosa strains.
Permeabilisation studies in P. aeruginosa demonstrated that the cellular membrane changes induced by 
membrane-active agents, EDTA, and polymyxin B and the synthetic peptide RTA3, were virtually absent in the 
presence of OligoG CF-5/20 (Fig. 2). Similarly, metabolomic-profiling studies demonstrated that bacterial growth 
with OligoG CF-5/20 was unaffected by changes in osmotic/ionic conditions (Fig. 3a,b). The lack of permeabilisa-
tion was supported by growth assays that showed only bacteriostatic activity with OligoG CF-5/203. Nevertheless, 
this could be advantageous as the development of many membrane-active antimicrobial agents has been ham-
pered by formulation difficulties and non-specific permeabilisation/toxicity concerns41. The putative membrane 
effect with OligoG CF-5/20 is supported by the absence of resistance to the drug during prolonged serial passage3.
Previous force-curve measurements on P. aeruginosa PAO1 biofilms showed a decrease in Young’s modulus 
when treated with OligoG CF-5/20 (20–100 mg/ml)9, which correlated with an alteration (3.1–6.0 mV decrease) 
in surface charge8. However, these results were not reflected in the LPS ELS analysis in this study (Fig. 3d). 
Conversely, previous studies have noted that ELS and AFM analysis for LPS may not always correlate, as bacterial 
adhesion can vary depending on LPS chain length42.
SANS and CD experiments were employed to gain a greater understanding of the interaction of OligoG 
CF-5/20 with Gram-negative cell wall components at the nanoscale. SANS has previously been used to analyse 
the structure of LPS and its derivatives, highlighting the different chemotypes of LPS (rough and smooth) and the 
importance of temperature control43–45. In these studies, colistin was used as a positive control due to its known 
ability to bind and neutralise bacterial LPS46 displacing cell wall-stabilising divalent cations in the outer mem-
brane47. Previous studies have investigated the direct interaction of colistin with LPS from Escherichia coli using 
turbidity, CD and SANS experiments30. Pseudomonal LPS aggregates demonstrated a high scattering intensity, 
I(Q) as a function of the wave-vector, Q, which was in line with the size, shape and distribution of E. coli LPS 
observed previously30. These studies, along with others48, have demonstrated that at neutral pH, LPS forms struc-
tures that are hundreds of nm in size but with a lamellar organization and bilayer thickness of ~5 nm. Similarly, 
the emergence of two peaks when LPS was treated with colistin, was accompanied by a pronounced increase in 
scattering intensity at low Q, as seen with E. coli LPS and colistin30. The conformation of the LPS was unaltered 
by OligoG CF-5/20 at all pHs and salt concentrations tested (Fig. 4a,b), which are comparable to those previ-
ously reported in PAO1 zeta potential analysis8. Similar to the current study, CD spectra of LPS-colistin mixtures 
showed no indication of conformational changes, but only changes that could be interpreted as simple additive 
effects (Fig. 4c,d).
Salt concentration and pH have a fundamental effect on bacterial surface charge, and these parameters are 
altered in CF patients during an exacerbation and when in remission. Several studies have shown a broad varia-
tion of acidity in the lung environment of a CF patient (pH 5–6) which is lowered during an exacerbation, while 
normal lung fluid pH is ~749,50. Similarly, the chloride concentration of CF lung fluid is abnormally high, due to 
defective chloride channels and/or chronic lung infection and inflammation with the chloride concentration of 
tracheal and bronchial airway surface fluid increasing from 85 ± 54 mM in healthy individuals to 129 ± 79 mM in 
CF patients51. Encouragingly, these studies demonstrate that OligoG CF-5/20 did not cause any conformational 
changes in LPS at physiological pH and salt concentrations.
The discovery that the antimicrobial activity of OligoG CF-5/20 does not depend on cell permeabilisation 
is promising, since this is the type of mechanism of action that is commonly found to be the cause of antibiotic 
resistance52. Colistin is increasingly being used for the treatment of MDR Gram-negative bacterial infections53 
and is the most commonly inhaled antibiotic treatment in CF54. The recent emergence of colistin resistance is of 
major concern55 and is linked to LPS modification56 possibly as a result of complete loss of LPS in strains such 
as Acinetobacter baumannii57. LPS modification mediated by the pmr operon is also known to enhance colistin 
resistance58. Recently, OligoG CF-5/20 has been shown to potentiate the effect of colistin against MDR pseu-
domonal pathogens, leading to a 128-fold reduction in the Minimum Biofilm Eradication Concentration value5.
A significant alteration in divalent cation levels has been reported in the CF lung (102 mg/l Ca2+) compared 
to 45 mg/l in a healthy control59. The effect of divalent metal ions in maintaining LPS structure has been well 
documented in the literature, with their depletion found to lead to a distinct outer membrane structure with an 
exposed peptidoglycan surface layer, and increased cell permeability40. Colistin is believed to electrostatically 
bind to the anionic phosphate groups on the LPS lipid A core, leading to displacement of the divalent cations 
which bridge the lipid A molecules and maintain cell wall integrity47. Previous in vivo MDR bacterial biofilm 
models of infection have demonstrated a dramatic reduction in biofilm growth (2.5-log fold) when OligoG 
CF-5/20 was administered intra-tracheally5.
Gram-negative bacteria do not exhibit membrane perturbation following binding. Instead we hypothesise that 
the anti-biofilm effects of OligoG CF-5/20 are mediated via interaction with the bacterial matrix of extracellular 
polysaccharide substance (EPS), removing this barrier and allowing more effective interaction of colistin with 
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the bacterial cell wall. This mechanism of action, by EPS disruption, may be promising in the treatment of MDR 
biofilm infections60.
Due to its overall negative charge, OligoG CF-5/20 did not self-aggregate in the absence of free Ca2+. However, 
Ca2+-induced self-aggregation can overcome the electrostatic repulsion between individual molecules, via the 
formation of salt bridges. In fact, previous calorimetric studies have shown similar Ca2+-mediated aggregation 
of alginates via so-called ‘egg-box’ dimers61. Unsurprisingly, the interaction between OligoG CF-5/20 and LPS 
was also found to be mediated by Ca2+, but the interaction was not sufficiently strong enough to allow analysis 
in terms of a simple binding model (stoichiometry and affinity). The ITC studies, concluding that only a weak 
(Ca2+-dependent) interaction between OligoG CF-5/20 and LPS occurred, alongside the physical analysis (ITC/
SANS/CD spectroscopy), all suggested that OligoG CF-5/20 did not significantly alter the structure of LPS. These 
interactions may, in part, be reflected in the bacterial aggregation observed in AFM.
In summary, OligoG CF-5/20 induced cellular aggregation of both S. mutans and P. aeruginosa, however, irre-
versible surface interaction of OligoG CF-5/20 was demonstrated with the Gram-negative cell. No increase in per-
meability of the membrane was detected when treated with OligoG CF-5/20. OligoG CF-5/20 also did not induce 
surface charge alterations of the LPS component of the outer membrane, nor did it neutralise or cause aggregation 
of LPS itself. Subtle changes in LPS conformation were recorded in solution following an increase in salt concen-
tration, however pH had no apparent effect. CD spectra for LPS remained unaltered by OligoG CF-5/20, as did 
the presence of Ca2+. ITC, however, showed a weak Ca2+ mediated interaction between OligoG CF-5/20 and LPS. 
Studies are ongoing to determine the molecular mechanism of action of the antimicrobial properties of OligoG 
CF-5/20. It is hoped that defining its mode of action will help with the advancement of future applications for this 
antimicrobial agent, to address the developmental need for new antimicrobial therapies.
Materials and Methods
Materials. OligoG CF-5/20 was synthesised as previously described3. Materials were obtained from the 
following companies: deuterium oxide (D2O; with 99.9% isotopic purity), LPS (from Pseudomonas aeruginosa 
10), Triton X-100, carboxyfluorescein (Cbfl), colistin sulphate, polymyxin B, Tris HCl, propidium iodide (PI), 
1-N-phenylnapthylamine (NPN), ethylenediaminetetraacetic acid (EDTA), sodium fluoride (Sigma-Aldrich, 
Gillingham, U.K.); sodium chloride (NaCl), calcium chloride (CaCl), hydrochloric acid, sodium hydroxide, ace-
tone (Fisher Scientific, Loughborough, U.K.); phosphate buffered saline (PBS) tablets, tryptic soy broth (TSB), 
Mueller-Hinton (MH) broth, (Oxoid, Basingstoke, U.K.); nitrocefin, (Calbiochem, Darmstadt, Germany); and 
egg phosphatidylcholine (PC), phosphatidylglycerol (PG), (Lipid Products, Nutfield, UK).
Bacteria, Media and Culture Conditions. Streptococcus mutans DSM 20523 (ATCC 25175) and 
Pseudomonas aeruginosa strains PAO1, V2 (MDR3) and NH57388A (mucoid variant) were grown on blood agar 
plates or in TSB overnight at 37 °C.
Atomic Force Microscopy Imaging. Bacterial cultures of S. mutans DSM 20523 (72 h) and P. aeruginosa 
(PAO1; 24 h) were grown in TSB at 37 °C. The overnight cultures were washed twice (5,500 g, 3 min) in dH2O and 
the bacteria were then incubated in 5–7 mg/ml OligoG CF-5/20 for 20 min. Excess OligoG CF-5/20 was removed 
(2,500 g, 6 min) before resuspending the bacterial cells in dH2O and drying on 0.01% poly-L-lysine coated mica 
plates for imaging. A Dimension 3100 AFM (Bruker) was employed, using tapping mode operation in air (0.8 Hz 
scan speed).
Membrane permeability studies. Release of carboxyfluorescein dye from a vesicular model of the bacterial 
membrane. This model, mimicking the Gram-negative bacterial inner membrane, was used to study membrane 
interactions with OligoG CF-5/20. Small unilamellar liposomes (100 nm) containing carboxyfluorescein (Cbfl; 
50 mM) were prepared from egg phospholipids employing the freeze/thaw pressure-extrusion method11,62 using 
egg phosphatidylcholine:phosphatidylglycerol at a ratio of 80:20 or 50:50 to mimic the Gram-negative bacterial 
inner membrane. Cbfl solutions were made by dissolving in 10 mM Tris and adding NaOH to bring the pH to 
7.4. Dried phospholipids were hydrated in Cbfl-containing Tris, pH 7.4, freeze-thawing 3 times to support the 
production of large multilamellar vesicles at a lipid concentration of 10 mg/ml, and then extruding 10 times 
through two 100 nm pore membranes. The resulting Cbfl-loaded 100 nm small unilamellar vesicles were sepa-
rated from external Cbfl by passing down a Sephadex G-15 gel filtration column equilibrated with 10 mM Tris, pH 
7.4 containing 107 mM NaCl to balance osmotically the internal Cbfl. Release of entrapped Cbfl in the presence 
of OligoG CF-5/20 (20, 60, 100 mg/ml) was measured in 10 mM Tris-HCl, 107 mM NaCl (pH 7.4) buffer by fluo-
rescence with λ ex = 490 nm and λ em = 520 nm over time (5 min). RTA311 (0.5 μ M) and Tris buffer alone were used 
as positive and negative controls, respectively.
Determination of membrane permeabilisation by nitrocefin and propidium iodide uptake of cells. Membrane per-
meabilisation of PAO1 was quantified by measuring cellular uptake of nitrocefin (a chromogenic β -lactamase 
substrate)63 or propidium iodide (PI)64. Cells were grown overnight in TSB, then diluted in PBS (pH 7.4) to an 
OD625 of 0.5. Cells were then washed twice by centrifugation at 3,500 g for 10 min at 25 °C to form a pellet, before 
being resuspended in PBS.
For the nitrocefin assay, OligoG CF-5/20 (0, 20, 60, 100 mg/ml) or EDTA (10 mM) dissolved in PBS (180 μ l) 
were added to the wells of a microtitre plate containing bacterial suspension (10 μ l). The plate was sealed with 
parafilm, incubated at 37 °C for 3 h and centrifuged at 12,000 g for 10 min. The supernatant (95 μ l) of each well 
was removed and transferred into the wells of a clean microtitre plate containing nitrocefin (0.5 mg/ml in 5% 
v/v DMSO, 5 μ l). Plates were incubated in the dark at 37 °C for 30 min before measuring the absorbance on a 
FLUOstar OPTIMA plate reader (BMG LABTEC) at 486 nm (n = 3).
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For the PI assay, OligoG CF-5/20 (0, 20, 60, 100 mg/ml) or EDTA (10 mM) dissolved in PBS (140 μ l) were 
added to the wells of a black microtitre plate containing bacterial suspension (10 μ l) and PI solution (1.5 mM in 
PBS, 50 μ l). Plates were incubated in the dark at 37 °C for 15 min before measuring fluorescence (λ ex = 480 nm, 
λ em = 612 nm). Fluorescence intensity was calculated by subtracting the baseline fluorescence of control cells (PBS 
only) from the total fluorescence of treated cells (n = 3).
1-N-phenylnaphthylamine (NPN) dye assay. Outer membrane permeabilisation of P. aeruginosa was quantified 
by measuring uptake of 1-N-phenylnapthylamine (NPN) dye into the bacterial cytoplasmic membrane65. Cells 
were grown overnight in TSB then diluted in PBS, pH 7.4, to an OD625 of 0.5. Cells were washed twice by centrif-
ugation at 4,000 rpm for 10 min at 25 °C and resuspended in PBS. Bacterial suspension (100 μ l) was added to the 
wells of a black 96-well plate and mixed with freshly prepared NPN solution (40 μ M in 8% v/v acetone; 50 μ l) and 
left to equilibrate at room temperature for 30 min. Solutions (50 μ l) of OligoG CF-5/20 (0, 2, 20 mg/ml) or pol-
ymyxin B (10 μ g/ml) were added to the wells and fluorescence was read immediately using the fluorescent plate 
reader (λ ex = 350 nm, λ em = 410 nm). Dye uptake was calculated by subtracting the baseline fluorescence of free 
NPN from the total fluorescence of treated cells (n = 12).
Effect of OligoG CF-5/20 under various osmolyte conditions. Metabolomic studies were employed 
to phenotypically screen for the effect of osmolytes on P. aeruginosa PAO1 using an osmotic/ionic response assay 
panel from BIOLOG (Haywood, CA, USA), a 96 well-plate containing different osmolytic conditions66. PAO1 was 
grown overnight on 5% Blood agar at 37 °C. OligoG CF-5/20 (20–60 mg/ml) was dissolved in Innoculating Fluid 
(IF) 10 (BIOLOG) and incubated at 37 °C for 20–30 min on a roller mixer until dissolved. The remaining ingre-
dients (inoculating fluid base, dye mix, cells and water) were added according to the manufacturers’ instructions 
prior to loading onto the BIOLOG PM09 plate (100 μ l/well). OligoG CF-5/20 and PAO1 only controls were also 
included. Plates were incubated in an Omnilog incubator at 37 °C for 120 h. As there was no change of activity 
after this time, results were taken at 48 h. Metabolic activity was analysed colorimetrically by measuring reduction 
of tetrazolium dye to insoluble formazan (purple colour) by cell respiration67 (n = 2). An OligoG CF-5/20 only 
control (≥ 60 mg/ml) was included to confirm that no colometric changes in the absence of PAO1 occurred.
Electrophoretic light scattering (zeta potential) measurements. The zeta potential of pseudomonal 
LPS (10 mg/ml) in the absence and presence of OligoG CF-5/20 (2 mg/ml) was determined using a Zetasizer 
Nano ZS (Malvern Instruments) with disposable capillary cells (DTS1061 Malvern Instruments) in 0.01 M NaCl, 
pH 5, 7 and 9, at 25 °C (n = 10).
Turbidity assay. A turbidimetric assay was used to measure the binding of OligoG CF-5/20 to LPS resulting 
from the precipitation of aggregates and increased turbidity. LPS was dissolved in pre-warmed PBS (10 mg/ml, 
37 °C, pH 7.4) containing OligoG CF-5/20 (2 and 20 mg/ml) and 200 μ l were added to the wells of a 96-well micr-
otitre plate. Control samples contained only LPS dissolved in PBS. Plates were incubated at 37 °C throughout the 
experiment and absorbance was read at 620 nm at time-points over 2 h. Samples were assayed in triplicate and 
means calculated.
Small angle neutron scattering (SANS). SANS experiments were performed either on the D11 
diffractometer at the steady-state reactor source ILL, Grenoble or on SANS2d at the spallation source at 
ISIS, Oxfordshire. For D11, measurements were performed at a constant neutron wavelength (λ ) of 6 Å and 
sample-detector distances of 1.2 m and 8 m to cover a Q range between 0.008 and 0.5 Å−1, whereas for SANS2D, 
neutron wavelengths spanning 2–14 Å were used to access a Q range 0.02 to 3 Å−1. In both cases, the samples were 
contained in 2 mm path-length, UV-spectrophotometer grade quartz cuvettes (Hellma, U.K.) and mounted in 
aluminium holders on top of an enclosed, computer-controlled, sample chamber. Sample volumes were around 
0.4 cm3. All experiments were conducted at 37 °C ± 0.2 °C. Experimental measuring times were approximately 
20 min.
To assess the salt- and pH-dependent solution conformation of OligoG CF-5/20, the polymer was dis-
solved (20 mg/ml) in D2O containing 0.001 M, 0.01 M or 0.1 M NaCl at pH 5, 7, or 9. To characterise the OligoG 
CF-5/20-LPS interaction, LPS (10 mg/ml) was incubated in the absence and presence of OligoG CF-5/20 (2, 
20 mg/ml) in D2O containing 0.001 M, 0.01 M or 0.1 M NaCl at pH 5, 7, or 9 for 3 h at 37 °C prior to analysis by 
SANS. Where relevant, calcium chloride was also included to the stated concentration.
All scattering data were (a) normalised for the sample transmission, (b) background corrected using a quartz 
cell filled with D2O, and (c) corrected for the linearity and efficiency of the detector response using the instrument 
specific software package.
The data without calcium were fitted to a model comprising a coexisting mixture of unilamellar vesicular and 
spherical micellar structures. However, when combined with calcium, a vesicular structure model, looking at the 
absolute scattering intensities was utilised43.
Circular dichroism spectroscopy. CD was used to study the interaction of LPS with OligoG CF-5/20. 
Spectra were recorded on an Aviv 215 spectrophotometer (Aviv Biomedical Inc., Lakewood, NJ) using 0.01cm 
quartz cuvettes. Samples were prepared by dilution from 25 mg/ml LPS and 50 mg/ml OligoG CF-5/20 stock 
solutions into the desired buffers and incubated for 3 to 6 h at 37 °C prior to measurements. Spectra were recorded 
using a 1 nm bandwidth, 0.2 nm intervals with 3 s accumulation time at 37 °C with a dynode voltage less than 
500 V. Buffer baselines recorded in the same cell with the same parameters were subtracted. Mean residue weight 
ellipticities are reported using 194 Da to represent the mass of the carbohydrate units.
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Isothermal Titration Calorimetry (ITC). Calorimetric titrations were carried out at 37 °C on a MicroCal 
PEAQ-ITC microcalorimeter (Malvern Instruments Ltd). The instrument was operated applying a reference 
power of 10 μ cal/s, in high feedback mode, stirring the sample cell contents at 750 rpm, with a pre-injection initial 
delay of 60 s. Freshly prepared solutions of LPS (10 mg/ml, ~0.5 mM) and OligoG CF-5/20 (20 mg/ml, ~6.25 mM) 
were loaded into the calorimeter sample cell and injection syringe respectively, using the required buffers. Buffers 
employed in the experiment were 100 mM NaCl, 20 mM NaH2PO4 (+ NaOH adjusted to pH 7) ± the addition of 
1 mM EDTA and/or CaCl2 (1 mM final free Ca2+). All experiments involved an initial injection of 0.4 μ L in 0.8 s 
followed by 18 further injections of 2.0 μ L in 4.0 s into the calorimeter sample cell. Injections were spaced by at 
least 90 s to allow full recovery of the baseline. Raw data was treated using MicroCal PEAQ-ITC Analysis Software 
(1.0.0.1259) to generate both integrated heat effects per injection (Δ Q) and molar heat effects per injection (Δ H).
Statistical analysis. The significance of the data was assessed using one-way analysis of variance (ANOVA) 
followed by Bonferroni’s post hoc test. Statistical significance was set at p < 0.05.
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